Peer-Review Report of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (10135)
All Articles published online
|
Publishing Process of This Article
|
Sep 28, 2016 (publication date) through May 20, 2026
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| Sposito C, Di Sandro S, Brunero F, Buscemi V, Battiston C, Lauterio A, Bongini M, De Carlis L, Mazzaferro V. Development of a prognostic scoring system for resectable hepatocellular carcinoma. World J Gastroenterol 2016; 22(36): 8194-8202 [PMID: 27688661 DOI: 10.3748/wjg.v22.i36.8194] |
|
|
|
| All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply. | |
| For: | Sposito C, Di Sandro S, Brunero F, Buscemi V, Battiston C, Lauterio A, Bongini M, De Carlis L, Mazzaferro V. Development of a prognostic scoring system for resectable hepatocellular carcinoma. World J Gastroenterol 2016; 22(36): 8194-8202 [PMID: 27688661 DOI: 10.3748/wjg.v22.i36.8194] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v22/i36/8194.htm |
| Number | Citing Articles |
| 1 |
Angelo Castello, Egesta Lopci. Imaging HCC treated with radioembolization: review of the literature and clinical examples of choline PET utility. Clinical and Translational Imaging 2020; 8(5): 377 doi: 10.1007/s40336-020-00384-y
|
| 2 |
Carlo Sposito, Michela Monteleone, Luca Aldrighetti, Umberto Cillo, Raffaele Dalla Valle, Alfredo Guglielmi, Giuseppe Maria Ettorre, Alessandro Ferrero, Fabrizio Di Benedetto, Giorgio Ettore Rossi, Luciano De Carlis, Felice Giuliante, Vincenzo Mazzaferro. Preoperative predictors of liver decompensation after mini-invasive liver resection. Surgical Endoscopy 2021; 35(2): 718 doi: 10.1007/s00464-020-07438-2
|
| 3 |
Hui-Chuan Sun, Lu Xie, Xin-Rong Yang, Wei Li, Jian Yu, Xiao-Dong Zhu, Yong Xia, Ti Zhang, Yang Xu, Bo Hu, Li-Ping Du, Ling-Yao Zeng, Jian Ouyang, Wei Zhang, Tian-Qiang Song, Qiang Li, Ying-Hong Shi, Jian Zhou, Shuang-Jian Qiu, Qian Liu, Yi-Xue Li, Zhao-You Tang, Yu Shyr, Feng Shen, Jia Fan. Shanghai Score. Chinese Medical Journal 2017; 130(22): 2650 doi: 10.4103/0366-6999.218019
|
| 4 |
Rokas Stulpinas, Dovile Zilenaite-Petrulaitiene, Allan Rasmusson, Aiste Gulla, Agne Grigonyte, Kestutis Strupas, Arvydas Laurinavicius. Prognostic Value of CD8+ Lymphocytes in Hepatocellular Carcinoma and Perineoplastic Parenchyma Assessed by Interface Density Profiles in Liver Resection Samples. Cancers 2023; 15(2): 366 doi: 10.3390/cancers15020366
|
| 5 |
Berend R. Beumer, Stefan Buettner, Boris Galjart, Jeroen L.A. van Vugt, Robert A. de Man, Jan N.M. IJzermans, Bas Groot Koerkamp. Systematic review and meta-analysis of validated prognostic models for resected hepatocellular carcinoma patients. European Journal of Surgical Oncology 2022; 48(3): 492 doi: 10.1016/j.ejso.2021.09.012
|
| 6 |
Shih-Da Chung, Chee-Chien Yong, Kwong-Ming Kee, Sheng-Nan Lu, Tsung-Hui Hu, Jing-Houng Wang, Chao-Hung Hung, Chien-Hung Chen, Yueh-Wei Liu, Wei-Feng Li, Chih-Chi Wang, Yi-Hao Yen, Chih-Yun Lin. Overall survival is comparable between percutaneous radiofrequency ablation and liver resection as first-line therapies for solitary 3–5 cm hepatocellular carcinoma. Langenbeck's Archives of Surgery 2025; 410(1) doi: 10.1007/s00423-025-03632-9
|
| 7 |
Ren-Cai Lu, Bo She, Wen-Tao Gao, Yun-Hai Ji, Dong-Dong Xu, Quan-Shi Wang, Shao-Bo Wang. Positron-emission tomography for hepatocellular carcinoma: Current status and future prospects. World Journal of Gastroenterology 2019; 25(32): 4682-4695 doi: 10.3748/wjg.v25.i32.4682
|
| 8 |
Masatoshi Kudo. Atezolizumab plus Bevacizumab Followed by Curative Conversion (ABC Conversion) in Patients with Unresectable, TACE-Unsuitable Intermediate-Stage Hepatocellular Carcinoma. Liver Cancer 2022; 11(5): 399 doi: 10.1159/000526163
|
| 9 |
Pauline Duquenne, Gabor Liposits, Cassandra O Vonnes, Erna Navarrete, Adolfo Gonzalez Serrano, Florence Canoui-Poitrine, Joana Marinho, Baran Akagündüz, Kristen R Haase, Haydee C Verduzco-Aguirre, Juan Li, Colm Mac Eochagáin, Enrique Soto-Perez-de-Celis, Ana Patricia Ayala, Joosje C Baltussen, Kavita Kantilal, Kumud Kantilal, Chan Wing-Lok, Andrea Perez de Acha, Shelby Meckstroth, Ana Cristina Torres Perez, Deniz Can Güven, Yue Zhao, Martine Puts, Bérengère Beauplet, Jennifer L Lund, Sophie Pilleron. Prediction models for overall survival and all-cause mortality risk in older adults with cancer: a systematic review. The Lancet Healthy Longevity 2026; 7(3): 100829 doi: 10.1016/j.lanhl.2026.100829
|